Race for coronavirus treatment - As the global race continues to try and find a treatment for coronavirus the UK biotech firm Synairgen is reportedly planning to trial its experimental lung drug on Covid-19 patients.
The company received the green light from UK regulators to conduct a trial of its lead drug SNG001 at NHS trusts across the country.
The inhaled drug has been in development as a treatment for chronic-obstructive pulmonary disorder (COPD), a severe lung disease, but this has been paused to conduct testing on 100 patients who have been diagnosed with Covid-19.
It was identified in a WHO analysis of potential treatments against the coronavirus. Patients can self-administer it, through a small hand-held battery-operated nebulizer.
The trial is due to start next week.
Figures have been released for hospitalizations from Covid-19 in the Var. As of yesterday, 19 October, there were 31 patients hospitalised, which is 4...
Read More
A bouncer of the well-known night club in Old Nice the Blue Whales, has been saved by his bulletproof vest. ...
Read More
A family in Cannes have been victims of a violent home-jacking. On Sunday evening two armed and hooded men entered their home. After assaulting the fa...
Read More
A court in Paris has issued a warrant compelling former president Nicolas Sarkosy to testify at a hearing. He will be obliged to attend the court as a...
Read More
A motorist has died in a road accident on the Moyenne Corniche this morning, Tuesday 19th October. Despite the intervention of witnesses, the driver d...
Read More
